| UniProt ID | SRBP1_MOUSE | |
|---|---|---|
| UniProt AC | Q9WTN3 | |
| Protein Name | Sterol regulatory element-binding protein 1 | |
| Gene Name | Srebf1 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 1134 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . Cytoplasmic vesicle, COPII-coated vesicle membrane Multi-pass membrane protein . Moves from the endoplasmic reticulum to the Gol |
|
| Protein Description | Transcriptional activator required for lipid homeostasis. Regulates transcription of the LDL receptor gene as well as the fatty acid and to a lesser degree the cholesterol synthesis pathway. Binds to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3'). Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3'). Isoform SREBP-1A is much more active than isoform SREBP-1C in stimulating transcription from SRE-1-containing promoters.. | |
| Protein Sequence | MDELAFGEAALEQTLAEMCELDTAVLNDIEDMLQLINNQDSDFPGLFDAPYAGGETGDTGPSSPGANSPESFSSASLASSLEAFLGGPKVTPAPLSPPPSAPAALKMYPSVSPFSPGPGIKEEPVPLTILQPAAPQPSPGTLLPPSFPAPPVQLSPAPVLGYSSLPSGFSGTLPGNTQQPPSSLPLAPAPGVLPTPALHTQVQSLASQQPLPASAAPRTNTVTSQVQQVPVVLQPHFIKADSLLLTAVKTDAGATVKTAGISTLAPGTAVQAGPLQTLVSGGTILATVPLVVDTDKLPIHRLAAGSKALGSAQSRGEKRTAHNAIEKRYRSSINDKIVELKDLVVGTEAKLNKSAVLRKAIDYIRFLQHSNQKLKQENLTLRSAHKSKSLKDLVSACGSGGGTDVSMEGMKPEVVETLTPPPSDAGSPSQSSPLSFGSRASSSGGSDSEPDSPAFEDSQVKAQRLPSHSRGMLDRSRLALCVLAFLCLTCNPLASLFGWGILTPSDATGTHRSSGRSMLEAESRDGSNWTQWLLPPLVWLANGLLVLACLALLFVYGEPVTRPHSGPAVHFWRHRKQADLDLARGDFPQAAQQLWLALQALGRPLPTSNLDLACSLLWNLIRHLLQRLWVGRWLAGQAGGLLRDRGLRKDARASARDAAVVYHKLHQLHAMGKYTGGHLAASNLALSALNLAECAGDAISMATLAEIYVAAALRVKTSLPRALHFLTRFFLSSARQACLAQSGSVPLAMQWLCHPVGHRFFVDGDWAVHGAPPESLYSVAGNPVDPLAQVTRLFREHLLERALNCIAQPSPGAADGDREFSDALGYLQLLNSCSDAAGAPACSFSVSSSMAATTGPDPVAKWWASLTAVVIHWLRRDEEAAERLYPLVEHIPQVLQDTERPLPRAALYSFKAARALLDHRKVESSPASLAICEKASGYLRDSLASTPTGSSIDKAMQLLLCDLLLVARTSLWQRQQSPASVQVAHGTSNGPQASALELRGFQHDLSSLRRLAQSFRPAMRRVFLHEATARLMAGASPARTHQLLDRSLRRRAGSSGKGGTTAELEPRPTWREHTEALLLASCYLPPAFLSAPGQRMSMLAEAARTVEKLGDHRLLLDCQQMLLRLGGGTTVTSS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 14 | Phosphorylation | GEAALEQTLAEMCEL HHHHHHHHHHHHHHC | 20.68 | - | |
| 63 | Phosphorylation | TGDTGPSSPGANSPE CCCCCCCCCCCCCCH | 30.41 | 23384938 | |
| 91 | Phosphorylation | FLGGPKVTPAPLSPP HHCCCCCCCCCCCCC | 21.62 | 25159016 | |
| 96 | Phosphorylation | KVTPAPLSPPPSAPA CCCCCCCCCCCCCCH | 34.01 | 26824392 | |
| 100 | Phosphorylation | APLSPPPSAPAALKM CCCCCCCCCCHHHHC | 53.29 | 25159016 | |
| 108 | Phosphorylation | APAALKMYPSVSPFS CCHHHHCCCCCCCCC | 7.26 | 17203969 | |
| 110 | Phosphorylation | AALKMYPSVSPFSPG HHHHCCCCCCCCCCC | 20.10 | 17203969 | |
| 112 | Phosphorylation | LKMYPSVSPFSPGPG HHCCCCCCCCCCCCC | 25.27 | 17203969 | |
| 115 | Phosphorylation | YPSVSPFSPGPGIKE CCCCCCCCCCCCCCC | 32.12 | 28066266 | |
| 249 | Ubiquitination | SLLLTAVKTDAGATV EEEEEEEECCCCCEE | 37.92 | 22790023 | |
| 276 | Ubiquitination | AVQAGPLQTLVSGGT EEECCCCEEEECCCE | 35.60 | 27667366 | |
| 278 | Ubiquitination | QAGPLQTLVSGGTIL ECCCCEEEECCCEEE | 1.54 | 27667366 | |
| 283 | Ubiquitination | QTLVSGGTILATVPL EEEECCCEEEEEEEE | 19.15 | 27667366 | |
| 284 | Ubiquitination | TLVSGGTILATVPLV EEECCCEEEEEEEEE | 2.52 | 27667366 | |
| 302 | Ubiquitination | DKLPIHRLAAGSKAL CCCCHHHHHHHHHHH | 2.07 | 27667366 | |
| 307 | Ubiquitination | HRLAAGSKALGSAQS HHHHHHHHHHCCHHH | 46.87 | 22790023 | |
| 331 | Phosphorylation | AIEKRYRSSINDKIV HHHHHHHHHHCHHHH | 27.00 | 19244231 | |
| 332 | Phosphorylation | IEKRYRSSINDKIVE HHHHHHHHHCHHHHH | 19.20 | 19244231 | |
| 336 | Ubiquitination | YRSSINDKIVELKDL HHHHHCHHHHHHHHH | 44.13 | 27667366 | |
| 375 | Ubiquitination | QHSNQKLKQENLTLR HHHCHHHHHHCCCHH | 63.70 | 22790023 | |
| 389 | Phosphorylation | RSAHKSKSLKDLVSA HHHHHCCCHHHHHHH | 47.98 | 21459323 | |
| 395 | Phosphorylation | KSLKDLVSACGSGGG CCHHHHHHHHCCCCC | 25.74 | 19244231 | |
| 419 | Phosphorylation | PEVVETLTPPPSDAG CHHEEECCCCCCCCC | 40.96 | - | |
| 441 | Phosphorylation | LSFGSRASSSGGSDS CCCCCCCCCCCCCCC | 24.75 | 26643407 | |
| 442 | Phosphorylation | SFGSRASSSGGSDSE CCCCCCCCCCCCCCC | 31.83 | 26643407 | |
| 443 | Phosphorylation | FGSRASSSGGSDSEP CCCCCCCCCCCCCCC | 44.68 | 26643407 | |
| 446 | Phosphorylation | RASSSGGSDSEPDSP CCCCCCCCCCCCCCC | 41.30 | 23684622 | |
| 448 | Phosphorylation | SSSGGSDSEPDSPAF CCCCCCCCCCCCCCC | 53.37 | 23684622 | |
| 452 | Phosphorylation | GSDSEPDSPAFEDSQ CCCCCCCCCCCCCHH | 28.92 | 28066266 | |
| 461 | Ubiquitination | AFEDSQVKAQRLPSH CCCCHHHHHHHCCCC | 31.03 | 22790023 | |
| 576 | Ubiquitination | VHFWRHRKQADLDLA CCCEECHHHHCHHHH | 43.65 | 22790023 | |
| 911 | Ubiquitination | RAALYSFKAARALLD HHHHHHHHHHHHHHC | 34.88 | 22790023 | |
| 980 | Phosphorylation | QRQQSPASVQVAHGT HHCCCCCCEEEEECC | 19.23 | 28059163 | |
| 994 | Phosphorylation | TSNGPQASALELRGF CCCCCCCCHHHHHCC | 28.30 | 28059163 | |
| 1006 | Phosphorylation | RGFQHDLSSLRRLAQ HCCCCCHHHHHHHHH | 33.12 | 25159016 | |
| 1007 | Phosphorylation | GFQHDLSSLRRLAQS CCCCCHHHHHHHHHH | 32.94 | 23140645 | |
| 1026 | Ubiquitination | MRRVFLHEATARLMA HHHHHHHHHHHHHHC | 50.27 | 27667366 | |
| 1028 | Ubiquitination | RVFLHEATARLMAGA HHHHHHHHHHHHCCC | 14.88 | 27667366 | |
| 1033 | Ubiquitination | EATARLMAGASPART HHHHHHHCCCCHHHH | 18.26 | 27667366 | |
| 1034 | Ubiquitination | ATARLMAGASPARTH HHHHHHCCCCHHHHH | 16.78 | 27667366 | |
| 1036 | Phosphorylation | ARLMAGASPARTHQL HHHHCCCCHHHHHHH | 20.41 | 28066266 | |
| 1047 | Phosphorylation | THQLLDRSLRRRAGS HHHHHHHHHHHHCCC | 26.37 | - | |
| 1052 | Ubiquitination | DRSLRRRAGSSGKGG HHHHHHHCCCCCCCC | 22.02 | 27667366 | |
| 1057 | Ubiquitination | RRAGSSGKGGTTAEL HHCCCCCCCCCCCCC | 56.99 | 27667366 | |
| 1086 | Ubiquitination | LASCYLPPAFLSAPG HHHHCCCHHHHCCCC | 32.80 | 27667366 | |
| 1108 | Ubiquitination | EAARTVEKLGDHRLL HHHHHHHHHCCCHHH | 54.13 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 331 | S | Phosphorylation | Kinase | SIK1 | Q60670 | Uniprot |
| 332 | S | Phosphorylation | Kinase | SIK1 | Q60670 | Uniprot |
| 389 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
| 389 | S | Phosphorylation | Kinase | AMPK | - | Uniprot |
| 395 | S | Phosphorylation | Kinase | SIK1 | Q60670 | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 389 | S | Phosphorylation |
| 21459323 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SRBP1_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PRGC2_MOUSE | Ppargc1b | physical | 20211142 | |
| ZBT7C_MOUSE | Zbtb7c | physical | 22331133 | |
| BRE1A_MOUSE | Rnf20 | physical | 24425205 | |
| NFIL3_MOUSE | Nfil3 | physical | 27252523 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "AMPK phosphorylates and inhibits SREBP activity to attenuate hepaticsteatosis and atherosclerosis in diet-induced insulin-resistantmice."; Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., Park O.,Luo Z., Lefai E., Shyy J.Y., Gao B., Wierzbicki M., Verbeuren T.J.,Shaw R.J., Cohen R.A., Zang M.; Cell Metab. 13:376-388(2011). Cited for: PHOSPHORYLATION AT SER-389, SUBCELLULAR LOCATION, AND MUTAGENESIS OFSER-354 AND SER-389. | |
| "Salt-inducible kinase regulates hepatic lipogenesis by controllingSREBP-1c phosphorylation."; Yoon Y.S., Seo W.Y., Lee M.W., Kim S.T., Koo S.H.; J. Biol. Chem. 284:10446-10452(2009). Cited for: PHOSPHORYLATION AT SER-331; SER-332 AND SER-395, AND MUTAGENESIS OFSER-331; SER-332 AND SER-395. | |
| "Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-108 AND SER-112, ANDMASS SPECTROMETRY. | |